PubRank

Anil Vachani

Author PubWeight™ 52.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol 2012 2.14
2 Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 2009 1.86
3 Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 2005 1.86
4 HIF-2alpha deletion promotes Kras-driven lung tumor development. Proc Natl Acad Sci U S A 2010 1.86
5 A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med 2013 1.69
6 Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. Oncotarget 2012 1.67
7 A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res 2007 1.47
8 Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine. Clin Cancer Res 2006 1.40
9 Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 2014 1.33
10 Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer. PLoS One 2010 1.31
11 Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. Cancer Res 2005 1.26
12 Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system. Clin Cancer Res 2011 1.24
13 A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. N Engl J Med 2015 1.22
14 Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin Cancer Res 2005 1.19
15 Advances in diagnostic bronchoscopy. Am J Respir Crit Care Med 2010 1.18
16 Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist? Lung Cancer 2013 1.16
17 Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest 2015 1.16
18 A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. Mol Ther 2010 1.15
19 Local and systemic recurrence is the Achilles heel of cancer surgery. Ann Surg Oncol 2011 1.15
20 Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther 2009 1.14
21 MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLoS One 2012 1.13
22 Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest 2015 1.11
23 Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. J Nutr 2006 1.10
24 Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury. Cancer Biol Ther 2009 1.08
25 A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma. Am J Respir Crit Care Med 2011 1.07
26 Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment. Am J Respir Crit Care Med 2009 1.02
27 Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS. Bioanalysis 2011 0.97
28 An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice. Am J Respir Crit Care Med 2015 0.96
29 Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer. PLoS One 2012 0.96
30 Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapies. Clin Lung Cancer 2013 0.93
31 8-Oxo-2'-deoxyguanosine as a biomarker of tobacco-smoking-induced oxidative stress. Free Radic Biol Med 2012 0.92
32 Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women. Rapid Commun Mass Spectrom 2011 0.92
33 Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J Clin Invest 2013 0.90
34 A population-based study of lung carcinoma in Pennsylvania: comparison of Veterans Administration and civilian populations. Cancer 2005 0.88
35 Pilot randomized study comparing two techniques of airway anaesthesia during curvilinear probe endobronchial ultrasound bronchoscopy (CP-EBUS). Respirology 2011 0.87
36 Urinary volatile compounds as biomarkers for lung cancer. Biosci Biotechnol Biochem 2012 0.87
37 Detection of extracellular RNAs in cancer and viral infection via tethered cationic lipoplex nanoparticles containing molecular beacons. Anal Chem 2013 0.87
38 Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lung. J Oncol Pract 2012 0.85
39 Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 0.85
40 Local and systemic thrombolytic therapy for acute venous thromboembolism. Clin Chest Med 2003 0.82
41 Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer. Mol Ther 2006 0.80
42 A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine. Rapid Commun Mass Spectrom 2011 0.80
43 Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions. Ann Am Thorac Soc 2013 0.79
44 Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma. J Thorac Oncol 2013 0.78
45 In vitro discrimination of tumor cell lines with an electronic nose. Otolaryngol Head Neck Surg 2007 0.78
46 Development of a genotyping microarray for studying the role of gene-environment interactions in risk for lung cancer. J Biomol Tech 2013 0.78
47 Quality indicators for the evaluation of patients with lung cancer. Chest 2014 0.76
48 Natural variation in the μ-opioid gene OPRM1 predicts increased pain on third day after thoracotomy. Clin J Pain 2012 0.76
49 Pharmacogenetics of gemtuzumab-associated hepatic sinusoidal occlusion syndrome after hematopoietic stem cell transplant. Acta Haematol 2003 0.75
50 The diagnostic efficacy of combining bronchoscopic tissue biopsy and endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of malignant lesions in the lung. Diagn Cytopathol 2012 0.75
51 Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med 2017 0.75
52 The changing face of outpatient bronchoscopy in 2013. Chest 2013 0.75
53 Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2017 0.75